SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is currently trending as traders and the community speculate on the upcoming maintenance data for its obesity candidate, VK2735. Sentiment is polarized, with bulls anticipating strong clinical results that could spark a partnership or buyout, while others express significant frustration with the CEO's communication style and the stock's recent price weakness.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions (FPS) is trending following its fiscal fourth-quarter results, which featured record bookings and a significant backlog, alongside strong fiscal 2027 guidance and a capacity-expanding investment in Tijuana. While the results drew investor enthusiasm, some traders are expressing frustration over volatility and lingering concerns about the impact of secondary share offerings on the stock's price.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

The conversation is dominated by frustration over the stock's poor price performance and ongoing volatility following recent acquisitions, with many traders debating whether the current price represents a buying opportunity or a deeper value trap. Sentiment is highly polarized between those betting on the long-term success of the leadership team and those blaming macroeconomic headwinds, dilution, and institutional manipulation for the persistent downward trend.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the release of final Phase 3 ORIGIN 3 trial data for its IgA nephropathy treatment, Trutakna, which demonstrated a 76% reduction in the risk of kidney disease progression. While some traders view the data as a milestone for full FDA approval, others are engaged in debate over competitive dynamics and the potential for short-term volatility.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's is trending following a significant share price decline triggered by a fiscal second-quarter earnings miss on both revenue and earnings per share. Traders are debating the viability of the company's "Back-to-Basics" turnaround strategy, with many expressing skepticism regarding declining entertainment sales and long-term debt levels, while some remain focused on the stock's potential for a short squeeze.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is facing market pressure following reports of a salmonella outbreak linked to jalapeños supplied to several restaurants, prompting a negative reaction despite the company's proactive removal of the ingredient. While some traders view the resulting price decline as an overreaction and a buying opportunity, others remain bearish, citing concerns over portion sizes, broader food safety risks, and potential long-term reputational damage.

Maase, Inc. operates as a integrated provider and operator of artificial intelligence (AI) centric full-scene digital systems. The firm focus on areas of flexible energy deployment and intelligent commercial network operation, and provide closed-loop solutions from computing infrastructure, smart hardware and full-scene services, aiming to achieve large-scale implementation of AI technologies across industries. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is trending as traders react to a series of enterprise AI compute and service agreements, including a recent contract with VirtAI Tech, which the community views as evidence of the company's shift toward high-margin AI infrastructure and enterprise revenue. While bulls highlight these agreements, the company's clean balance sheet, and its pivot away from legacy businesses, others caution that the rapid share price volatility reflects speculative trading patterns common among low-float Chinese ADRs.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon shares are experiencing significant volatility following a announced $1 billion offering of convertible senior notes, with the community divided between investors viewing the capital raise as an accretive growth opportunity and others expressing concern over potential future dilution. Market participants are also debating the stock's high valuation multiples and the impact of recent insider selling activity.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following strong Q2 earnings results, highlighted by impressive revenue growth and healthy same-restaurant sales that exceeded analyst expectations. While the stock initially experienced volatility due to industry-wide food safety concerns, the community is largely bullish, citing the company's strong unit expansion and debt-free balance sheet as key long-term catalysts.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is receiving significant attention following the successful financing of its planned Iridium acquisition and the completion of its large-scale at-the-market share offering, which traders view as removing a major capital overhang. Community discussion is split between bullish sentiment regarding the company's long-term growth as a vertically integrated space operator and bearish concerns over dilution, valuation, and delays in its Neutron rocket program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. It is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm's portfolio consists of four novel peptide therapy areas: autoimmunity, metabolism, cancer and anti-infectives. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.

Immupharma Plc

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Fundamentals

Info

IMMPF News